Carvedilol for children and adolescents with heart failure: a randomized controlled trial.
about
Beta-blockers for congestive heart failure in childrenMedical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancerMedical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancerBeta-blockers for congestive heart failure in childrenBeta blockers for congestive heart failure in childrenCONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials"Nihilism" of chronic heart failure therapy in children and why effective therapy is withheldPaediatric cardiovascular clinical trials: an analysis of ClinicalTrials.gov and the Food and Drug Administration Pediatric Drug Labeling DatabaseLong term negative pressure ventilation: Rescue for the failing fontan?Duchenne muscular dystrophy: the management of scoliosisHeart Failure in ChildrenMolecular Mechanisms of Right Ventricular FailureClinical research careers: reports from a NHLBI pediatric heart network clinical research skills development conferenceHeart Failure in Pediatric Patients With Congenital Heart Disease.Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer.The ventricular volume variability study of the Pediatric Heart Network: study design and impact of beat averaging and variable type on the reproducibility of echocardiographic measurements in children with chronic dilated cardiomyopathy.Neuregulin stimulation of cardiomyocyte regeneration in mice and human myocardium reveals a therapeutic window.A systematic review of the reporting of Data Monitoring Committees' roles, interim analysis and early termination in pediatric clinical trials.Recovery of echocardiographic function in children with idiopathic dilated cardiomyopathy: results from the pediatric cardiomyopathy registry.The Total Artificial Heart in End-Stage Congenital Heart DiseaseIs there a role for carvedilol in the management of pediatric heart failure? A meta analysis and e-mail survey of expert opinion.Anti-hypertensive drugs in children and adolescentsMicroRNAs in right ventricular (dys)function (2013 Grover Conference series).Routine echocardiography screening for asymptomatic left ventricular dysfunction in childhood cancer survivors: a model-based estimation of the clinical and economic effects.Massive Cardiomegaly due to Dilated Cardiomyopathy Causing Bronchial Obstruction in an Infant.Gene expression and β-adrenergic signaling are altered in hypoplastic left heart syndrome.Pediatric heart transplantation-indications and outcomes in the current era.Controlled trials in children: quantity, methodological quality and descriptive characteristics of pediatric controlled trials published 1948-2006.Anthracycline-associated cardiotoxicity in survivors of childhood cancer.Adrenergic receptor genotype influences heart failure severity and β-blocker response in children with dilated cardiomyopathy.Cardiomyopathy of Friedreich's ataxia: use of mouse models to understand human disease and guide therapeutic development.Age-related differences in phosphodiesterase activity and effects of chronic phosphodiesterase inhibition in idiopathic dilated cardiomyopathy.Pediatric heart failure: current state and future possibilities.The impact of heart failure severity at time of listing for cardiac transplantation on survival in pediatric cardiomyopathy.The Heart in Friedreich's Ataxia: Basic Findings and Clinical Implications.Pediatric cardiovascular drug trials, lessons learned.Effects of steroids and angiotensin converting enzyme inhibition on circumferential strain in boys with Duchenne muscular dystrophy: a cross-sectional and longitudinal study utilizing cardiovascular magnetic resonance.Safety of aprotinin in congenital heart operations: results from a large multicenter database.Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.Usefulness of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide as biomarkers for heart failure in young children with single ventricle congenital heart disease.
P2860
Q24186346-B9418282-9F5B-4D70-B119-5E37EC02BAD8Q24234511-D66BF62C-DE18-4C7A-9440-5B981FA2E435Q24241097-983D9BD9-3341-4F70-9BCC-96B04809CE44Q24241410-3B517AD9-D3C7-4EA2-BD18-046F358A6222Q24243333-F2ADEAC8-1DBB-4168-90BC-EADA4B7C8BBCQ24614627-D32E7539-0704-4C66-A8BD-C7EF192A04B1Q26768688-31E39A32-2464-4392-9CDD-39A1C30675DBQ26786027-50B9653E-729A-4D23-B964-638FA284DFEEQ27003366-EB7A83D9-D70F-4658-AF53-2BBE6A2864A5Q28067793-F86E89FF-A916-49D5-A582-6448471F5F5FQ28078446-14D6EF65-98B6-41E1-82B9-6F07F821C3A7Q28087397-CE289687-5A98-4C04-815C-34FF8154923FQ28703857-0556C7AC-CA74-4D9E-8282-2026BF2AB1A6Q30235239-CC9BD311-CE81-493F-8946-473621C371D2Q30248340-B888648C-01C1-404A-9F4D-8994BD4237D6Q30535250-6965185E-708E-4CDB-BD4A-AB0F527990ECQ30842578-E304340E-1912-4A44-82A3-7099D6B9A137Q33517961-BAA51F15-83AC-4AEE-B19C-6B688BA06EE4Q33646290-63A8A885-B281-41D6-97DD-DBCDC0836200Q33650322-4807DEAF-014D-4350-90F1-92A80BFAE61CQ33735757-72C2A5C1-CE0D-401A-9751-B4A07DC2B332Q33772773-569A5E82-51BD-4151-BFFE-D7FB72E013AAQ33806013-9B03DD4C-268C-47DF-8CFA-44C8459B1FFEQ33873865-8704D7FA-1AEB-4949-B257-DC4516C7F7A9Q33896319-70A22491-F882-4CF8-B4FB-89487D92100FQ33954281-65A860EE-7FC0-4766-B8E2-BE3C0D2CABCAQ34048053-A77EC94C-D98B-4AEF-9782-822FB06F0D4CQ34166213-C02D5D9C-B55E-4B08-8084-FF073D116D3BQ34626238-997B0458-5FE4-4BFA-90B4-2EDF15A57A3AQ34981129-DDEB763D-7B62-4010-B804-17C82EE2ACE1Q34989407-9C1C2E0A-0053-4808-AD46-5441C356E84DQ35002036-3CD70473-9E54-4E52-8AA3-64F5C21EA807Q35028584-561B20F7-C42F-4F01-B7F7-D8DFD8D2D5D0Q35032826-79BDB4BA-10DE-4AFF-86EF-68F77B951497Q35052617-DC6564ED-E40A-4D9E-97BC-E3BE0D5BCAB5Q35085596-5A797532-82F7-4848-8551-069771B371FDQ35521574-67AA3D7D-CB5D-4E75-978A-6531060D64F9Q35687875-4724FA3B-C1C5-421B-8B61-A0C24AC0DE74Q35797623-42DD1A27-37AC-46E9-8BBB-50F07CD9E889Q35803749-3048EF0D-2D6A-4F2D-9B59-F4358262CEFE
P2860
Carvedilol for children and adolescents with heart failure: a randomized controlled trial.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Carvedilol for children and ad ...... a randomized controlled trial.
@en
type
label
Carvedilol for children and ad ...... a randomized controlled trial.
@en
prefLabel
Carvedilol for children and ad ...... a randomized controlled trial.
@en
P2093
P356
P1476
Carvedilol for children and adolescents with heart failure: a randomized controlled trial
@en
P2093
Bernie LaSalle
Charles E Canter
Debra A Dodd
Elfriede Pahl
Elizabeth D Blume
Lloyd Y Tani
Lynn Mahony
Mark M Boucek
Mary Ann Lukas
P304
P356
10.1001/JAMA.298.10.1171
P407
P577
2007-09-01T00:00:00Z